BioNTech SE (BNTX) Gross Profit Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -33.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360.36% |
| Sep 30, 2025 | 36.88% |
| Jun 30, 2025 | 817.89% |
| Mar 31, 2025 | -17.59% |
| Dec 31, 2024 | -118.35% |
| Sep 30, 2024 | 46.60% |
| Jun 30, 2024 | -656.28% |
| Mar 31, 2024 | -104.28% |
| Dec 31, 2023 | -66.52% |
| Sep 30, 2023 | -70.76% |
| Jun 30, 2023 | -99.80% |
| Mar 31, 2023 | -77.77% |
| Dec 31, 2022 | -26.21% |
| Sep 30, 2022 | -61.96% |
| Jun 30, 2022 | -51.30% |
| Mar 31, 2022 | 160.40% |
| Dec 31, 2021 | -100.00% |
| Sep 30, 2021 | 10,038.44% |
| Jun 30, 2021 | 13,300.85% |
| Mar 31, 2021 | 8,989.94% |
| Dec 31, 2020 | 1,392,179,133.11% |
| Sep 30, 2020 | 160.45% |
| Jun 30, 2020 | 74.36% |
| Mar 31, 2020 | -7.65% |
| Dec 31, 2019 | -61.49% |
| Sep 30, 2019 | 32.66% |